NCT02967692
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02967692
Title A Study of the Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma (COMBI-i)
Acronym COMBI-i
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | SWE | POL | NOR | NLD | ITA | ISR | HUN | GRC | GBR | FRA | ESP | DNK | DEU | CZE | CHE | CAN | BRA | BGR | BEL | AUT | AUS | ARG

Facility Status City State Zip Country Details
California Cancer Associates for Research and Excellence Encinitas California 92024 United States Details
UC Irvine Medical Center Orange California 92613-4091 United States Details
California Pacific Medical Center San Francisco California 94115 United States Details
Stanford Cancer Center Stanford California 94305 United States Details
University of Kansas Cancer Center Westwood Kansas 66205 United States Details
Johns Hopkins U Lutherville Maryland 21093 United States Details
Nebraska Cancer Specialists Omaha Nebraska 68130 United States Details
NYU Laura and Isaac Perlmutter Cancer Center New York New York 10016 United States Details
University of Pittsburgh Med Center Pittsburgh Pennsylvania 15213 United States Details
University of Tennessee Medical Ctr Knoxville Tennessee 37920 United States Details
Univ of TX MD Anderson Cancer Cntr Houston Texas 77030 United States Details
Utah Cancer Specialists Salt Lake City Utah 84106 United States Details
Novartis Investigative Site CABA Buenos Aires C1125ABD Argentina Details
Novartis Investigative Site CABA Buenos Aires C1426ANZ Argentina Details
Novartis Investigative Site Rosario Santa Fe Province S2000KZE Argentina Details
Novartis Investigative Site Caba C1431FWO Argentina Details
Novartis Investigative Site Gateshead New South Wales 2290 Australia Details
Novartis Investigative Site North Sydney New South Wales 2060 Australia Details
Novartis Investigative Site Greenslopes Queensland 4120 Australia Details
Novartis Investigative Site Melbourne Victoria 3004 Australia Details
Novartis Investigative Site Nedlands Western Australia 6009 Australia Details
Novartis Investigative Site Innsbruck Tyrol 6020 Austria Details
Novartis Investigative Site Graz 8036 Austria Details
Novartis Investigative Site Linz 4020 Austria Details
Novartis Investigative Site Salzburg A-5020 Austria Details
Novartis Investigative Site Sankt Pölten 3100 Austria Details
Novartis Investigative Site Brussels 1090 Belgium Details
Novartis Investigative Site Brussels 1200 Belgium Details
Novartis Investigative Site Curitiba Paraná 80530 010 Brazil Details
Novartis Investigative Site Porto Alegre Rio Grande do Sul 90035-003 Brazil Details
Novartis Investigative Site São Paulo São Paulo 01246 000 Brazil Details
Novartis Investigative Site Rio de Janeiro 20560-120 Brazil Details
Novartis Investigative Site Plovdiv 4004 Bulgaria Details
Novartis Investigative Site Sofia 1303 Bulgaria Details
Novartis Investigative Site Vancouver British Columbia V5Z 4E6 Canada Details
Novartis Investigative Site Toronto Ontario M4N 3M5 Canada Details
Novartis Investigative Site Montreal Quebec H3T 1E2 Canada Details
Novartis Investigative Site Montreal Quebec H4A 3J1 Canada Details
Novartis Investigative Site Sherbrooke Quebec J1H 5N4 Canada Details
Novartis Investigative Site Temuco Región de la Araucanía 4810469 Chile Details
Novartis Investigative Site Santiago 7500921 Chile Details
Novartis Investigative Site Santiago 8420383 Chile Details
Novartis Investigative Site Brno Czech Republic 656 53 Czechia Details
Novartis Investigative Site Zlín Czech Republic 762 75 Czechia Details
Novartis Investigative Site Hradec Králové CZE 500 05 Czechia Details
Novartis Investigative Site Ostrava Poruba 708 52 Czechia Details
Novartis Investigative Site Olomouc 779 00 Czechia Details
Novartis Investigative Site Prague 100 34 Czechia Details
Novartis Investigative Site Prague 12808 Czechia Details
Novartis Investigative Site Aarhus N 8200 Denmark Details
Novartis Investigative Site Limoges Haute Vienne 87000 France Details
Novartis Investigative Site Amiens 80054 France Details
Novartis Investigative Site Besançon 25030 France Details
Novartis Investigative Site Bobigny 93009 France Details
Novartis Investigative Site Bordeaux 33075 France Details
Novartis Investigative Site Boulogne-Billancourt 92104 France Details
Novartis Investigative Site Caen 14033 France Details
Novartis Investigative Site Clermont-Ferrand 63003 France Details
Novartis Investigative Site Dijon 21034 France Details
Novartis Investigative Site Grenoble 38043 France Details
Novartis Investigative Site Le Mans 72000 France Details
Novartis Investigative Site Lille 59037 France Details
Novartis Investigative Site Lorient 56322 France Details
Novartis Investigative Site Lyon 69373 France Details
Novartis Investigative Site Marseille 13885 France Details
Novartis Investigative Site Mulhouse 68070 France Details
Novartis Investigative Site Nice 06202 France Details
Novartis Investigative Site Paris 75475 France Details
Novartis Investigative Site Pierre-Bénite 69495 France Details
Novartis Investigative Site Poitiers 86021 France Details
Novartis Investigative Site Reims 51092 France Details
Novartis Investigative Site Rouen 76031 France Details
Novartis Investigative Site Strasbourg 67091 France Details
Novartis Investigative Site Toulouse 31059 France Details
Novartis Investigative Site Vandœuvre-lès-Nancy 54519 France Details
Novartis Investigative Site Villejuif 94800 France Details
Novartis Investigative Site Mannheim Baden-Wurttemberg 68305 Germany Details
Novartis Investigative Site Regensburg Bavaria 93053 Germany Details
Novartis Investigative Site Leipzig Saxony 04103 Germany Details
Novartis Investigative Site Halle Saxony-Anhalt 06120 Germany Details
Novartis Investigative Site Berlin 13353 Germany Details
Novartis Investigative Site Berlin 13578 Germany Details
Novartis Investigative Site Bonn 53105 Germany Details
Novartis Investigative Site Chemnitz 09117 Germany Details
Novartis Investigative Site Dresden 01307 Germany Details
Novartis Investigative Site Düsseldorf 40225 Germany Details
Novartis Investigative Site Erfurt 99089 Germany Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Freiburg im Breisgau 79106 Germany Details
Novartis Investigative Site Gera 07548 Germany Details
Novartis Investigative Site Hamburg 20246 Germany Details
Novartis Investigative Site Hanover 30625 Germany Details
Novartis Investigative Site Heidelberg 69120 Germany Details
Novartis Investigative Site Homburg 66421 Germany Details
Novartis Investigative Site Kiel 24105 Germany Details
Novartis Investigative Site Mainz 55131 Germany Details
Novartis Investigative Site Marburg 35039 Germany Details
Novartis Investigative Site Minden 32429 Germany Details
Novartis Investigative Site München 81377 Germany Details
Novartis Investigative Site Münster 48157 Germany Details
Novartis Investigative Site Stade 21682 Germany Details
Novartis Investigative Site Tübingen 72076 Germany Details
Novartis Investigative Site Athens 115 27 Greece Details
Novartis Investigative Site Athens 18547 Greece Details
Novartis Investigative Site Budapest H 1122 Hungary Details
Novartis Investigative Site Debrecen 4032 Hungary Details
Novartis Investigative Site Szeged H 6725 Hungary Details
Novartis Investigative Site Haifa 3109601 Israel Details
Novartis Investigative Site Jerusalem 9112001 Israel Details
Novartis Investigative Site Ramat Gan 5265601 Israel Details
Novartis Investigative Site Bari BA 70124 Italy Details
Novartis Investigative Site Bergamo BG 24127 Italy Details
Novartis Investigative Site Bologna BO 40138 Italy Details
Novartis Investigative Site Brescia BS 25123 Italy Details
Novartis Investigative Site Meldola FC 47014 Italy Details
Novartis Investigative Site Genova GE 16132 Italy Details
Novartis Investigative Site Monza MB 20900 Italy Details
Novartis Investigative Site Milan MI 20133 Italy Details
Novartis Investigative Site Milan MI 20141 Italy Details
Novartis Investigative Site Modena MO 41124 Italy Details
Novartis Investigative Site Padua PD 35100 Italy Details
Novartis Investigative Site Roma RM 00167 Italy Details
Novartis Investigative Site Siena SI 53100 Italy Details
Novartis Investigative Site Candiolo TO 10060 Italy Details
Novartis Investigative Site Torino TO 10126 Italy Details
Novartis Investigative Site Verona VR 37134 Italy Details
Novartis Investigative Site Napoli 80131 Italy Details
Kyushu University Hospital Fukuoka Fukuoka 812-8582 Japan Details
Kyoto University Hospital Sakyo Ku Kyoto 606 8507 Japan Details
Osaka International Cancer Institute Osaka Osaka 541-8567 Japan Details
Tokyo Metropolitan Komagome Hospital Bunkyo Ku Tokyo 113-8677 Japan Details
National Cancer Hospital Chuo Ku Tokyo 104 0045 Japan Details
Novartis Investigative Site León Guanajuato 37178 Mexico Details
Novartis Investigative Site Guadalajara Jalisco 44100 Mexico Details
Novartis Investigative Site Mexico City Mexico City 14080 Mexico Details
Novartis Investigative Site Leiden South Holland 2333 Netherlands Details
Novartis Investigative Site Amersfroort 3818 ES Netherlands Details
Novartis Investigative Site Oslo 0310 Norway Details
Novartis Investigative Site Gdansk 80 952 Poland Details
Novartis Investigative Site Warsaw 02 781 Poland Details
Novartis Investigative Site Lisbon 1099 023 Portugal Details
Novartis Investigative Site Porto 4200-072 Portugal Details
Novartis Investigative Site Chelyabinsk 454048 Russia Details
Novartis Investigative Site Moscow 115478 Russia Details
Novartis Investigative Site Moscow 143423 Russia Details
Novartis Investigative Site Nizhny Novgorod 603137 Russia Details
Novartis Investigative Site Omsk 644013 Russia Details
Novartis Investigative Site Saint Petersburg 197758 Russia Details
Novartis Investigative Site Saint Petersburg 198255 Russia Details
Novartis Investigative Site Samara 443011 Russia Details
Novartis Investigative Site Málaga Andalusia 29010 Spain Details
Novartis Investigative Site Seville Andalusia 41009 Spain Details
Novartis Investigative Site Jerez de la Frontera Cadiz 11407 Spain Details
Novartis Investigative Site Badalona Catalonia 08916 Spain Details
Novartis Investigative Site Barcelona Catalonia 08036 Spain Details
Novartis Investigative Site A Coruña Galicia 15006 Spain Details
Novartis Investigative Site Oviedo Principality of Asturias 33011 Spain Details
Novartis Investigative Site Valencia Valencia 46014 Spain Details
Novartis Investigative Site Las Palmas de Gran Canaria 35016 Spain Details
Novartis Investigative Site Madrid 28009 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Madrid 28050 Spain Details
Novartis Investigative Site Madrid 28222 Spain Details
Novartis Investigative Site Gothenburg SE-413 45 Sweden Details
Novartis Investigative Site Lund 221 85 Sweden Details
Novartis Investigative Site Stockholm SE 171 76 Sweden Details
Novartis Investigative Site Aarau Canton of Aargau 5001 Switzerland Details
Novartis Investigative Site Zurich 8091 Switzerland Details
Novartis Investigative Site Songkhla Hat Yai 90110 Thailand Details
Novartis Investigative Site Bangkok 10330 Thailand Details
Novartis Investigative Site Truro Cornwall TR1 3LJ United Kingdom Details
Novartis Investigative Site Guildford Surrey GU2 7XX United Kingdom Details
Novartis Investigative Site Sutton Surrey SM2 5PT United Kingdom Details
Novartis Investigative Site Leicester LE1 5WW United Kingdom Details
Novartis Investigative Site London NW3 2QG United Kingdom Details
Novartis Investigative Site Manchester M20 2BX United Kingdom Details
Novartis Investigative Site Middlesbrough TS4 3BW United Kingdom Details
Novartis Investigative Site Preston PR2 9HT United Kingdom Details
Novartis Investigative Site Rickmansworth Road WD187HT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field